Visual Universitätsmedizin Mainz

Ausgewählte Publikationen

Researcher ID

Für eine vollständige Liste der Publikationen klicken Sie bitte auf das ResearcherID Icon. Dort kann auch die Zitationshäufigkeit abgerufen werden.

For a complete list of publications please click on the ResearcherID button. There also citation metrics can be found.

    • Pieper N, Zaremba A, Leonardelli S, Harbers FN, Schwamborn M, Lübcke S, Schrörs B, Baingo J, Schramm A, Haferkamp S, Seifert U, Sucker A, Lennerz V, Wölfel T, Schadendorf D, Schilling B, Paschen A, Zhao F. Evolution of melanoma cross-resistance to CD8+ T cells and MAPK inhibition in the course of BRAFi treatment. OncoImmunology 2018; 1-31
    • Schroers B, Lübcke S, Lennerz V, Fatho M, Bicker A, Wölfel C, Derigs P, Hankeln T, Schadendorf D, Paschen A, Wölfel T. HLA class I loss in metachronous metastases prevents continous T cell recognition of mutated neoantigens in a human melanoma model. Oncotarget 2017; 8 (17): 28312-28327.
    • Zhao F, Sucker A, Horn S, Heeke C, Bielefeld N, Schrörs B, Bicker A, Lindemann M, Roesch A, Gaudernack G, Stiller M, Becker JC, Lennerz V, Wölfel T, Schadendorf D, Griewank K, Paschen A. Melanoma Lesions Independently Acquire T-Cell Resistance during Metastatic Latency. Cancer Res. 2016;76(15):4347-58.
       
    • Singh VK, Werner S, Hackstein H , Lennerz V, Reiter A, Wölfel T, Damm-Welk C, Woessmann W. Analysis of NPM-ALK-reactive CD8-positive T cell responses in children with NPM-ALK positive anaplastic large cell lymphoma. Clin Exp Immunol. 2016;186(1):96-105.
       
    • Gross S, Lennerz V, Gallerani E, Mach N, Böhm S, Hess D, von Boehmer L, Knuth A, Ochsenbein A, Gnad-Vogt U, Forssmann U, Woelfel T, Kaempgen E. Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers. Cancer Immunol Res. 2016;4(1):18-25.
       
    • Pritchard AL, Burel, JG, Neller MA, Hayward, NK, Lopez JA, Fatho M, Lennerz V, Wölfel T, Schmidt CW. Exome sequencing to predict neoantigens in melanoma. Cancer Immunol Res. 2015;3(9):992-8.
       
    • Lennerz V, Gross S, Gallerani E, Sessa C, Mach N, Boehm S, Hess D, von Boehmer L, Knuth A, Ochsenbein AF, Gnad-Vogt U, Zieschang J, Forssmann U, Woelfel T, Kaempgen E. Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors. Cancer Immunol Immunother. 2014;63(4):381-94.
       
    • Landsberg J, Kohlmeyer J, Renn M, Bald T, Rogava M, Cron M, Fatho M, Lennerz V, Wölfel T, Hölzel M, Tüting T. Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature. 2012;490(7420):412-6.
       
    • Wölfel C, Lennerz V, Lindemann E, Hess G, Derigs HG, Huber C, Herr W, Wölfel T. Dissection and molecular analysis of alloreactive CD8+ T cell responses in allogeneic haematopoietic stem cell transplantation. Cancer Immunol Immunother. 2008;57(6):849-57.
       
    • Britten CM, Gouttefangeas C, Welters MJ, Pawelec G, Koch S, Ottensmeier C, Mander A, Walter S, Paschen A, Müller-Berghaus J, Haas I, Mackensen A, Køllgaard T, thor Straten P, Schmitt M, Giannopoulos K, Maier R, Veelken H, Bertinetti C, Konur A, Huber C, Stevanović S, Wölfel T, van der Burg SH. The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays. Cancer Immunol Immunother. 2008;57(3):289-302.
       
    • Graf C, Heidel F, Tenzer S, Radsak MP, Solem FK, Britten CM, Huber C, Fischer T, Wölfel T. A neoepitope generated by an FLT3 internal tandem duplication (FLT3-ITD) is recognized by leukemia-reactive autologous CD8+ T cells. Blood. 2007;109(7):2985-8.
       
    • Lennerz V, Fatho M, Gentilini C, Frye RA, Lifke A, Ferel D, Wölfel C, Huber C, Wölfel T. The response of autologous T cells to a human melanoma is dominated by mutated neoantigens. Proc Natl Acad Sci U S A. 2005;102(44):16013-8.